Abstract
[(18)F]Fluoro-2-deoxyglucose positron emission tomography (FDG-PET) is a useful tool for measuring the regional cerebral metabolic rate of glucose (rCMRglu), which is an index of neuronal activity. Donepezil, an acetylcholine esterase inhibitor (AChEI), has been recommended as a treatment option for patients with Alzheimer's disease (AD). We aimed to characterize the effects of donepezil on rCMRglu using FDG-PET in non-human primates. We investigated the effects of administration of donepezil (500 microg/kg, i.m.), the non-selective muscarinic ACh receptor antagonist scopolamine (30 microg/kg, i.m.), and the coadministration of both drugs on the rCMRglu of conscious young rhesus monkeys. Donepezil increased the rCMRglu in all regions of interest except in the thalamus. Scopolamine treatment also increased the rCMRglu in all regions of interest except the cerebellum and thalamus. However, these effects disappeared with coadministration of the drugs. This PET study showed that administration of donepezil or scopolamine alone increased the rCMRglu in conscious rhesus monkeys. We also found that the donepezil-induced increase was abolished by simultaneous administration of scopolamine, suggesting that muscarinic ACh receptor functi...Continue Reading
References
Nov 1, 1979·Annals of Neurology·M E PhelpsD E Kuhl
May 1, 1977·Journal of Neurochemistry·L SokoloffM Shinohara
Jun 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M ReivichA Anand
Nov 14, 1994·Brain Research·H OnoeY Watanabe
Jan 28, 1994·Brain Research·J BlinT N Chase
Aug 1, 1997·Neuroscience·M G VannucchiF Casamenti
Jun 1, 1997·Psychopharmacology·N M RupniakM J Field
Sep 8, 2000·Annals of Neurology·D E KuhlR A Koeppe
Dec 29, 2000·Japanese Journal of Pharmacology·K MishimaM Fujiwara
May 24, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Alexander DrzezgaAlexander Kurz
Jan 13, 2004·International Journal of Geriatric Psychiatry·Roy W JonesRanbir Bahra
May 11, 2004·Drugs & Aging·David G WilkinsonJennifer Payne-Parrish
Feb 9, 2005·Behavioural Brain Research·Nelson De-MelloAntonio P Carobrez
May 11, 2005·Archives of Neurology·Michael S MegaJeffrey L Cummings
Jun 7, 2005·Pharmacology, Biochemistry, and Behavior·Amity GreenPradeep J Nathan
Jul 29, 2005·Journal of Neural Transmission·E StefanovaA Nordberg
Oct 11, 2005·The Journal of Pharmacology and Experimental Therapeutics·C M HernandezA V Terry
Jan 28, 2006·European Journal of Pharmacology·Rui D S PredigerReinaldo N Takahashi
Jun 13, 2006·Psychopharmacology·Stefan J TeipelHarald Hampel
Dec 16, 2006·Current Medicinal Chemistry·Pedro J Modrego
Mar 24, 2007·Neurobiology of Aging·A KadirA Nordberg
Aug 21, 2007·Biochemical Pharmacology·Jerry J BuccafuscoMurali Gopalakrishnan
Citations
Aug 30, 2011·Neurología : publicación oficial de la Sociedad Española de Neurología·A ToledanoC I Fernández-Verdecia
Sep 6, 2013·British Journal of Pharmacology·Russell H Swerdlow
May 21, 2013·NeuroImage·O M DoyleA F Marquand
Aug 25, 2016·BioMed Research International·Ilhan LimJin Su Kim